DCGI nod for restricted emergency use of indigenous mRNA COVID jab for 18 years and above
The drug regulator also approved Serum Institute’s Covovax for restricted emergency use in children aged 7 to 11 The drug regulator also approved Serum Institute’s Covovax for restricted emergency use in children aged 7 to 11 The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine against COVID-19 manufactured […]
Continue Reading
